New Delhi: India's listed hospitals are likely to maintain double-digit revenue growth even as EBITDA margins stay rangebound due to a hectic bed-addition cycle, brokerage firm Kotak Securities said in a research report.
With ARPOB growth of 6-14 per cent YoY for most players, strong Inpatient Department volumes and diagnostics B2C traction picking up, the brokerage sees top-line momentum holding.
